GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 33 filers reported holding GALMED PHARMACEUTICALS LTD in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $4,111,000 | +38.1% | 860,103 | 0.0% | 0.30% | +9.3% |
| Q1 2020 | $2,976,000 | -58.3% | 860,103 | -11.5% | 0.27% | -59.6% |
| Q2 2019 | $7,139,000 | -10.0% | 971,337 | 0.0% | 0.67% | -15.4% |
| Q1 2019 | $7,936,000 | +19.6% | 971,337 | 0.0% | 0.79% | -6.6% |
| Q4 2018 | $6,634,000 | -42.6% | 971,337 | +14.1% | 0.85% | -27.3% |
| Q3 2018 | $11,563,000 | +22.6% | 851,492 | +7.4% | 1.16% | -4.1% |
| Q2 2018 | $9,433,000 | – | 792,707 | – | 1.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 202,100 | $2,318,000 | 1.99% |
| Gerry Farber, LLC | 52,000 | $596,000 | 1.03% |
| Granite Point Capital Management, L.P. | 115,000 | $1,319,000 | 0.94% |
| 683 Capital Management, LLC | 158,735 | $1,821,000 | 0.71% |
| SPHERA FUNDS MANAGEMENT LTD. | 170,000 | $1,950,000 | 0.44% |
| Knoll Capital Management, LLC | 65,000 | $746,000 | 0.39% |
| Healthcare Value Capital, LLC | 50,000 | $574,000 | 0.38% |
| Park West Asset Management LLC | 200,000 | $2,294,000 | 0.26% |
| Perceptive Advisors | 75,000 | $860,000 | 0.09% |
| HIGHLAND CAPITAL MANAGEMENT LP | 126,956 | $1,456,000 | 0.06% |